Stock listing
NASDAQ:FATE Fate Therapeutics, Inc. Stock
Home listing (NASDAQ) of Fate Therapeutics, Inc.
Follow Fate Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:FATE
$2.08 USD -0.09 (-4.1%)
Close on Oct 30, 2026
- Day range
- $2.01 – $2.17 USDOct 30, 2026
- Volume
- 1.06M sharesOct 30, 2026
- Market cap
- $249.2M USDAt the close on Oct 30, 2026 · price × 119.8M shares outstanding
- 52-week range
- $0.95 – $3.23 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $3.82M USDMedian day 1.22M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:FATE · Home | $2.08 USD | -0.09 (-4.1%) | 1,064,416 | $2.13 | $2.165 | $2.01 | $2.17 | Close on Oct 30, 2026 |
| Frankfurt:F6T | €1.832 EUR | +0.057 (+3.2%) | — | €1.832 | €1.832 | €1.832 | €1.775 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:FATE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.08 | -0.09 | -4.1% | $2.13 | $2.165 | $2.01 | 1,064,416 | |
| $2.17 | 0.00 | 0.0% | $2.17 | $2.23 | $2.12 | 804,285 | |
| $2.17 | +0.10 | +4.8% | $2.04 | $2.18 | $2.035 | 1,105,653 | |
| $2.07 | +0.015 | +0.7% | $2.05 | $2.09 | $2.03 | 923,555 | |
| $2.055 | -0.055 | -2.6% | $2.10 | $2.14 | $2.04 | 1,460,281 | |
| $2.11 | +0.02 | +1.0% | $2.08 | $2.135 | $2.015 | 1,111,188 | |
| $2.09 | +0.02 | +1.0% | $2.07 | $2.11 | $2.035 | 867,180 | |
| $2.07 | +0.01 | +0.5% | $2.06 | $2.14 | $2.045 | 1,215,151 | |
| $2.06 | +0.20 | +10.8% | $1.86 | $2.145 | $1.84 | 1,772,349 | |
| $1.86 | +0.07 | +3.9% | $1.79 | $1.90 | $1.75 | 1,683,530 | |
| $1.79 | -0.135 | -7.0% | $1.94 | $1.975 | $1.78 | 1,384,493 | |
| $1.925 | -0.015 | -0.8% | $1.96 | $1.995 | $1.91 | 1,157,826 | |
| $1.94 | -0.06 | -3.0% | $1.95 | $1.99 | $1.89 | 1,674,322 | |
| $2.00 | -0.13 | -6.1% | $2.13 | $2.13 | $1.98 | 953,482 | |
| $2.13 | -0.05 | -2.3% | $2.13 | $2.18 | $2.104 | 616,845 | |
| $2.18 | +0.05 | +2.3% | $2.13 | $2.275 | $2.10 | 773,466 | |
| $2.13 | -0.02 | -0.9% | $2.12 | $2.13 | $2.03 | 1,475,882 | |
| $2.15 | -0.14 | -6.1% | $2.28 | $2.30 | $2.14 | 863,011 | |
| $2.29 | -0.14 | -5.8% | $2.43 | $2.49 | $2.285 | 1,135,795 | |
| $2.43 | +0.11 | +4.7% | $2.32 | $2.575 | $2.29 | 3,381,444 | |
| $2.32 | +0.02 | +0.9% | $2.34 | $2.36 | $2.27 | 658,023 | |
| $2.30 | -0.07 | -3.0% | $2.37 | $2.39 | $2.285 | 812,976 | |
| $2.37 | -0.01 | -0.4% | $2.40 | $2.495 | $2.355 | 1,078,057 | |
| $2.38 | 0.00 | 0.0% | $2.37 | $2.41 | $2.29 | 1,443,069 | |
| $2.38 | +0.03 | +1.3% | $2.30 | $2.42 | $2.27 | 1,157,049 | |
| $2.35 | +0.02 | +0.9% | $2.34 | $2.465 | $2.27 | 3,387,241 | |
| $2.33 | -0.10 | -4.1% | $2.43 | $2.43 | $2.27 | 1,178,682 | |
| $2.43 | -0.15 | -5.8% | $2.57 | $2.585 | $2.43 | 909,697 | |
| $2.58 | +0.05 | +2.0% | $2.55 | $2.63 | $2.51 | 1,664,044 | |
| $2.53 | 0.00 | 0.0% | $2.52 | $2.575 | $2.44 | 1,266,691 | |
| $2.53 | +0.01 | +0.4% | $2.59 | $2.609 | $2.475 | 4,186,790 | |
| $2.52 | +0.08 | +3.3% | $2.48 | $2.685 | $2.46 | 5,137,160 | |
| $2.44 | +0.09 | +3.8% | $2.35 | $2.465 | $2.345 | 1,277,015 | |
| $2.35 | +0.01 | +0.4% | $2.33 | $2.40 | $2.27 | 828,371 | |
| $2.34 | +0.03 | +1.3% | $2.30 | $2.40 | $2.28 | 645,660 | |
| $2.31 | -0.02 | -0.9% | $2.36 | $2.39 | $2.30 | 742,393 | |
| $2.33 | -0.11 | -4.5% | $2.42 | $2.45 | $2.28 | 751,111 | |
| $2.44 | -0.06 | -2.4% | $2.48 | $2.52 | $2.424 | 553,575 | |
| $2.50 | +0.02 | +0.8% | $2.45 | $2.55 | $2.395 | 1,918,069 | |
| $2.48 | +0.06 | +2.5% | $2.38 | $2.49 | $2.38 | 611,433 | |
| $2.42 | -0.03 | -1.2% | $2.45 | $2.505 | $2.40 | 715,437 | |
| $2.45 | +0.02 | +0.8% | $2.43 | $2.505 | $2.38 | 1,218,923 | |
| $2.43 | +0.04 | +1.7% | $2.35 | $2.48 | $2.335 | 1,041,342 | |
| $2.39 | -0.04 | -1.6% | $2.40 | $2.435 | $2.365 | 549,268 | |
| $2.43 | -0.11 | -4.3% | $2.51 | $2.53 | $2.41 | 714,904 | |
| $2.54 | -0.03 | -1.2% | $2.56 | $2.595 | $2.505 | 1,574,944 | |
| $2.57 | +0.02 | +0.8% | $2.54 | $2.60 | $2.50 | 1,050,526 | |
| $2.55 | +0.11 | +4.5% | $2.46 | $2.62 | $2.455 | 2,439,393 | |
| $2.44 | +0.11 | +4.7% | $2.34 | $2.45 | $2.23 | 1,310,854 | |
| $2.33 | -0.12 | -4.9% | $2.46 | $2.508 | $2.32 | 1,697,067 | |
| $2.45 | -0.20 | -7.5% | $2.65 | $2.65 | $2.44 | 1,568,668 | |
| $2.65 | +0.09 | +3.5% | $2.61 | $2.70 | $2.59 | 1,216,805 | |
| $2.56 | -0.06 | -2.3% | $2.59 | $2.63 | $2.534 | 942,751 | |
| $2.62 | +0.05 | +1.9% | $2.57 | $2.70 | $2.51 | 3,183,645 | |
| $2.57 | +0.05 | +2.0% | $2.58 | $2.60 | $2.48 | 1,995,029 | |
| $2.52 | -0.20 | -7.4% | $2.83 | $2.85 | $2.51 | 2,367,266 | |
| $2.72 | -0.02 | -0.7% | $2.75 | $2.805 | $2.69 | 1,230,019 | |
| $2.74 | -0.02 | -0.7% | $2.79 | $2.82 | $2.69 | 1,283,220 | |
| $2.76 | -0.04 | -1.4% | $2.85 | $2.85 | $2.74 | 1,949,805 | |
| $2.80 | +0.31 | +12.4% | $2.53 | $2.88 | $2.483 | 4,015,589 | |
| $2.49 | -0.11 | -4.2% | $2.64 | $2.64 | $2.455 | 2,227,408 | |
| $2.60 | +0.03 | +1.2% | $2.615 | $2.675 | $2.56 | 3,387,489 | |
| $2.57 | +0.07 | +2.8% | $2.53 | $2.69 | $2.412 | 6,440,801 | |
| $2.50 | +0.05 | +2.0% | $2.43 | $2.55 | $2.37 | 1,252,982 | |
| $2.45 | -0.06 | -2.4% | $2.51 | $2.555 | $2.39 | 1,459,168 | |
| $2.51 | +0.15 | +6.4% | $2.36 | $2.55 | $2.345 | 1,698,291 |
- Ticker
- NASDAQ:FATE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 36 slides
Calls
Replays
Fate Therapeutics (NASDAQ:FATE) Q1 2024 Earnings Call
Thu, May 09, 2024 · 5:00 PM ET
Watch TranscriptFate Therapeutics (NASDAQ:FATE) Q4 2023 Earnings Call
Mon, Feb 26, 2024 · 5:00 PM ET
Watch TranscriptFate Therapeutics (NASDAQ:FATE) Q3 2023 Earnings Call
Wed, Nov 08, 2023 · 5:00 PM ET
Watch Transcript
Latest news
Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026
Oct 26, 2026
Closed $2.06 (-2.6%) on Oct 26, 2026
Fate Therapeutics Appoints Jamie Harrell as Senior Vice President, Market Development & Commercial Operations to Lead the Commercialization of CAR T-cell Therapies
Oct 12, 2026
Closed $2.13 (-2.3%) on Oct 12, 2026
Fate Therapeutics Reports New Employee Inducement Awards under Nasdaq Listing Rule 5635(4)
Oct 5, 2026
Closed $2.43 (+4.7%) on Oct 5, 2026
Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences
Oct 1, 2026
Closed $2.30 (-3.0%) on Oct 1, 2026
Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN
Sep 25, 2026
Closed $2.35 (+0.9%) on Sep 25, 2026
Fate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence 2026
Sep 16, 2026
Closed $2.44 (+3.8%) on Sep 16, 2026
Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR - West 2026 Meeting
Sep 10, 2026
Closed $2.33 (-4.5%) on Sep 10, 2026
Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference
Sep 3, 2026
Closed $2.42 (-1.2%) on Sep 3, 2026
Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis
Aug 14, 2026
Closed $2.57 (+2.0%) on Aug 14, 2026
Fate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
Aug 13, 2026
Closed $2.52 (-7.4%) on Aug 13, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 36 slides · August 2026
Investor Presentation (June 2026)
Investor deck · 32 slides · Jun 4, 2026
ASGCT Annual Meeting 2026
Conference · 13 slides · May 14, 2026
Investor Presentation (December 2025)
Investor deck · 38 slides · December 2025
Fate Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 33 in the last 12 months · 174 in all · newest Oct 26, 2026 · oldest 2019
- Calls
- 14 calls with a replay · 14 with a transcript · latest May 9, 2024
- Decks
- 19 decks · latest August 2026
Where Fate Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:FATE · Home listing · This page | NASDAQ | United States | USD |
| gettex:F6T | gettex | Germany | EUR |
| Lang & Schwarz:A1W50M | Lang & Schwarz | Germany | EUR |
| BOATS:FATE | BOATS | United States | USD |
| LS Exchange:A1W50M | LS Exchange | Germany | EUR |
| Frankfurt:F6T | Frankfurt | Germany | EUR |
| Stuttgart:F6T | Stuttgart | Germany | EUR |
| Dusseldorf:F6T | Dusseldorf | Germany | EUR |
| Munich:F6T | Munich | Germany | EUR |
| Tradegate:F6T | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Fate Therapeutics, Inc.